|
20 Nov 2018 |
DBV Technologies Presents Data at ACAAI 2018 on Investigational Viaskin Peanut for the Treatment of Peanut-Allergic Children
|
|
20 Nov 2018 |
Emergent BioSolutions and Valneva Report Positive Phase 1 Results for Their Vaccine Candidate Against the Zika Virus
|
|
14 Nov 2018 |
Merck Begins Rolling Submission of Licensure Application for V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration
|
|
13 Nov 2018 |
Transgene - Positive Results from Phase 1 Clinical Trial of TG1050 in Chronic Hepatitis B Presented at the AASLD Liver Meeting 2018
|
|
09 Nov 2018 |
Gradalis® Presents Initial Data from Phase II U.S. Trial for Ewing’s sarcoma at the Annual Meeting of the Children’s Oncology Group
|
|
08 Nov 2018 |
Neovacs announces in vivo Proof of Concept success for its IL-4 / IL-13 Kinoid a new Therapeutic Vaccine to treat Mite-induced Asthma
|
|
05 Nov 2018 |
Curevo Announces FDA Advancement of IND Application for CRV-101, New Shingles Vaccine Candidate
|
|
05 Nov 2018 |
Imcyse successfully completes patient enrollment in first-in-human Phase 1b study in type 1 diabetes
|
|
02 Nov 2018 |
Bavarian Nordic Announces Initiation of Clinical Trial Evaluating the Combination Therapy of CV301 and Durvalumab in Metastatic Colorectal and Pancreatic Cancers
|
|
31 Oct 2018 |
Daiichi Sankyo Announces Discontinuation of Intradermal Seasonal Influenza Vaccine Development in Japan
|
|
30 Oct 2018 |
Generex Biotechnology Announces IND Filing for a Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (Keytruda®) for the Treatment of Triple-Negative Breast Cancer
|
|
25 Oct 2018 |
Inovio HIV Vaccine PENNVAX®-GP Delivered Intradermally Generated Robust, Long-Term Best-In-Class Antibody and T Cell Immune Responses
|
|
25 Oct 2018 |
Johnson & Johnson Announces Promising, Early-Stage Results for Tetravalent Mosaic-based HIV Preventive Vaccine Regimen
|
|
24 Oct 2018 |
InvVax Achieves Preclinical Milestone with Universal Flu Vaccine Candidate
|
|
23 Oct 2018 |
Trial to provide first-in-human data for CureVac’s novel mRNA-based intramuscular rabies vaccine
|
|
23 Oct 2018 |
Inovio presents progression free survival & PSA doubling time improvements in prostate cancer patients treated with INO-5150
|
|
23 Oct 2018 |
Sellas Life Sciences - SELLAS Life Sciences Announces Positive Final Data in Triple Negative Breast Cancer Patients from Phase 2b Clinical Trial of Nelipepimut-S (NeuVax™) in Combination with Trastuzumab (Herceptin®) Presented at the European Society for
|
|
22 Oct 2018 |
DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration
|
|
19 Oct 2018 |
Sanofi receives positive CHMP opinion for dengue vaccine
|
|
16 Oct 2018 |
Aimmune Therapeutics Announces Initiation of Phase 2 Study With Regeneron and Sanofi of AR101 With Adjunctive Dupilumab in Peanut-Allergic Patients
|
|
16 Oct 2018 |
Targovax Reports Encouraging Disease-free Survival (DFS) Data From Tg01 Trial in Resected Pancreatic Cancer
|
|
16 Oct 2018 |
Inovio’s Ebola Vaccine Provides 100% Protection And Elicits Long-Lasting Immune Responses in Preclinical Studies
|
|
10 Oct 2018 |
OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Submission of Investigational New Drug Application to Evaluate Tedopi® in Combination with Nivolumab in Pancreatic Cancer
|
|
10 Oct 2018 |
IAVI Announces Clinical Trial of Next-Generation HIV Vaccine Candidate Designed to Induce Antibodies to Block HIV Infection
|
|
05 Oct 2018 |
New Data from Phase 2 Flu Challenge Study Demonstrates Vaxart’s Oral H1 Flu Vaccine Generated Protective Mucosal Immunity
|
